• Multi-omics deep learning model predicts anti-EGFR therapy response in liver metastases

    A multi-center study developed a deep learning framework integrating multi-omics data to predict which RAS wild-type colorectal cancer liver metastases patients will benefit from cetuximab therapy, addressing primary resistance challenges. (Curr Cancer Drug Targets)